Last reviewed · How we verify
ES009
At a glance
| Generic name | ES009 |
|---|---|
| Sponsor | Elpiscience Biopharma Australia Pty. Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ES009 CI brief — competitive landscape report
- ES009 updates RSS · CI watch RSS
- Elpiscience Biopharma Australia Pty. Ltd. portfolio CI